nach oben

Sleep and Biological Rhythms

Erschienen in:

01.01.2021 | Original Article

Effects of stimulant treatment on sleep in attention deficit hyperactivity disorder (ADHD)

verfasst von: Miriam Sanabra, Tary Gómez-Hinojosa, Carlota Alcover, Oscar Sans, Jose A. Alda

Erschienen in: Sleep and Biological Rhythms | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

The main objective of this study is to assess the prevalence of sleep disorders in treatment-naïve children and adolescents with ADHD compared with healthy controls matched for age and gender; and, at the same time, to determine whether stimulant medication (methylphenidate) affects sleep in the same group of children and adolescents with ADHD (naïve) after a 3-month treatment. A total of 120 children and adolescents (60 newly diagnosed with ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM IV), and 60 gender- and age-matched controls) were evaluated through objective (actigraphy) and subjective (sleep diary) measures. Later, of those 60 newly diagnosed with ADHD, 30 started pharmacological treatment with methylphenidate with a mean daily dose of 0.58 mg/kg. No significant differences in both measures within the ADHD group after following the 3-month pharmacological treatment with methylphenidate were found. There were neither any significant differences in sleep parameters through objective measures between the medication-naïve ADHD group and the control group, while significant differences were found through sleep diary (registered by parents) in latency and efficiency (p = < 0.05). These findings suggest that patients receiving a mean daily dose of 0.58 mg/kg of methylphenidate for 3 months did not experience sleep disturbances, based on objective (actigraphy) and subjective data. In addition, sleep problems in ADHD subjects may be overestimated by parents due to ADHD symptomatology.

Thomas R, Sanders S, Doust J, Beller E, Glaszious P. Prevalence of attention-deficit / hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994–1001. https://doi.org/10.1542/peds.2014-3482. CrossRefPubMed

Becker SP, Langberg JM, Evans SW. Sleep problems predict comorbid externalizing behaviors and depression in young adolescents with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2015;24(8):897–907. https://doi.org/10.1007/s00787-014-0636-6. CrossRefPubMed

Mindell JA, Meltzer LJ. Behavioural sleep disorders in children and adolescents. Ann Acad Med Singapore. 2008;37(8):722–8. PubMed

Le Cornu F, Dimitriou D. Poor sleep has negative implications for children with and without ADHD, but in different ways. Behav Sleep Med. 2017;17(4):423–36. https://doi.org/10.1080/15402002.2017.1395335. CrossRef

Sung V, Hiscock H, Sciberras E, Efron D. Sleep problems in children with attention-deficit/hyperactivity disorder: prevalence and the effect on the child and family. Arch Pediatr Adolesc Med. 2008;162(4):336–42. https://doi.org/10.1001/archpedi.162.4.336. CrossRefPubMed

Chamorro M, Lara JP, Insa I, Espadas M, Alda-díez JA. Evaluación y tratamiento de los problemas de sueño en niños diagnosticados de trastorno por déficit de atención/hiperactividad: actualización de la evidencia. Rev Neurol. 2017;64(9):413–21. https://doi.org/10.33588/rn.6409.2016539.

Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents—assessment of adverse events in non-randomised studies. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.CD012069.pub2. CrossRefPubMedPubMedCentral

Catalá-López F, Hutton B, Núñez-Beltrán A, Mayhew AD, Page MJ, Ridao M, et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials. Syst Rev. 2015;4(19):1–10. https://doi.org/10.1371/journal.pone.0180355.eCollection. CrossRef

Cortese S. Are the effects of methylphenidate uncertain? Irish J Psychol Med. 2018;35:163–7. https://doi.org/10.1017/ipm.2018.16. CrossRef

10.

Steingard R, Taskiran S, Connor DF, Markowitz JS, Stein MA. New formulations of stimulants: an update for clinicians. J Child Adolesc Psychopharmacol. 2019;29(5):324–39. https://doi.org/10.1089/cap.2019.0043. CrossRefPubMedPubMedCentral

11.

Catalá-López F, Hutton B. Comment digital health interventions for children with ADHD. Lancet Digit Heal. 2020;7500(20):1–2. https://doi.org/10.1371/journal.pone.0180355. CrossRef

12.

Chin WC, Huang YS, Chou YH, Wang C-H, Chen K-T, Fu J, et al. Subjective and objective assessments of sleep problems in children with attention deficit/hyperactivity disorder and the effects of methylphenidate treatment. Biomed J. 2018;41(6):356–63. https://doi.org/10.1016/j.bj.2018.10.004. CrossRefPubMed

13.

Cohen-Zion M, Ancoli-Israel S. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies. Sleep Med Rev. 2004;8(5):379–402. https://doi.org/10.1016/j.smrv.2004.06.002. CrossRefPubMed

14.

Kosse RC, Bouvy ML, Philbert D, de Vries TW, Koster ES. Attention-deficit/hyperactivity disorder medication use in adolescents: the patient’s perspective. J Adolesc Heal. 2017;61(5):619–25. https://doi.org/10.1016/j.jadohealth.2017.05.027. CrossRef

15.

Clavenna A, Bonati M. Pediatric pharmacoepidemiology—safety and effectiveness of medicines for ADHD. Expert Opin Drug Saf. 2017;16(12):1335–45. https://doi.org/10.1080/14740338.2017.1389894. CrossRefPubMed

16.

Caye A, Swanson JM, Coghill D, Rohde LA. Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Mol Psychiatry. 2018;24(3):390–408. https://doi.org/10.1038/s41380-018-0116-3. CrossRefPubMed

17.

Ricketts EJ, Sturm A, McMakin DL, McGuire JF, Tan PZ, Smalberg FB, et al. Changes in sleep problems across Attention-deficit/hyperactivity disorder treatment: findings from the multimodal treatment of attention-deficit/hyperactivity disorder study. J Child Adolesc Psychopharmacol. 2018;28(10):690–8. https://doi.org/10.1089/cap.2018.0038. CrossRefPubMedPubMedCentral

18.

Stuckert G, O’Laughlin L, Brubaker B. Attention Deficit Hyperactivity Disorder and sleep disturbances: consideration of parental influence. Behav Sleep Med. 2012;10(1):41–53. https://doi.org/10.1080/15402002.2012.636274. CrossRef

19.

Stein MA, Weiss M, Hlavaty L. ADHD Treatments, sleep, and sleep problems: Complex associations. Neurotherapeutics. 2012;9(3):509–17. https://doi.org/10.1007/s11920-017-0860-0. CrossRefPubMedPubMedCentral

20.

Huang Y-S, Tsai M-H, Guilleminault C. Pharmacological treatment of ADHD and the short and long term effects on sleep. Curr Pharm Des. 2011;17(15):1450–8. https://doi.org/10.2174/138161211796197179. CrossRefPubMed

21.

Corkum P, Tannock R, Moldofsky H, Hogg-Johnson S, Humphries T. Actigraphy and parental ratings of sleep in children with ADHD. Pediatr Sleep. 2001;24(3):303. https://doi.org/10.1093/sleep/24.3.303. CrossRef

22.

Corkum P, Panton R, Ironside S, MachPherson M, Williams T. Response: acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder. J Pediatr Psychol. 2007;34(1):110–2. https://doi.org/10.1093/jpepsy/jsn109. CrossRef

23.

Pliszka SR, Wilens TE, Bostrom S, Arnold VK, Marraffino A, Cutler AJ, et al. Efficacy and safety of HLD200, delayed-release and extended-release methylphenidate, in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2017;27(6):474–82. https://doi.org/10.1089/cap.2017.0084. CrossRefPubMedPubMedCentral

24.

Wechsler D. WISC-IV: escala de inteligencia de wechsler para Niños-IV. Madrid: TEA Ediciones; 2005.

25.

Soutullo C. Traducción al Español de la Entrevista Diagnóstica: Kiddie-schedule for affective disorders and schizophrenia, present and lifetime version (K-SADS-PL, 1996). 1996. https://www.cun.es/dam/cun/archivos/pdf/psiquiatria-psicologia-medica/KSADSEsp.pdf.

26.

DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD rating scale—IV: checklists, norms, and clinical interpretation. New York: The Guilford Press; 1998.

27.

Conners C, Sitarenios G, Parker J, Epstein J. The revised Conners’ parent rating scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol. 1998;26(4):257–68. CrossRef

28.

Achenbach TM, Rescorla L. Manual for the ASEBA school-age forms & profiles. Burlington: University of Vermont, Research Center for Children, Youth, & Families; 2001.

29.

Bergwerff C, Luman M, Oosterlaan J. No objectively measured sleep disturbances in children with attention-deficit/hyperactivity disorder. J Sleep Res. 2016;25(5):534–40. https://doi.org/10.1111/jsr.12399. CrossRefPubMed

30.

Owens J, Sangal R, Sutton V, Bakken R. Subjective and objective measures of sleep in children with attention-deficit/hyperactivity disorder. Sleep Med. 2009;10(4):446–56. https://doi.org/10.1016/j.sleep.2008.03.013. CrossRefPubMed

31.

Solleveld MM, Schrantee A, Baek HK, Bottelier MA, Tamminga HGH, Bouziane C, et al. Effects of 16 weeks of methylphenidate treatment on actigraph-assessed sleep measures in medication-naive children with ADHD. Front Psychiatry. 2020;11(February):1–9. https://doi.org/10.3389/fpsyt.2020.00082. CrossRef

32.

Corkum P, Begum EA, Rusak B, Rajda M, Shea S, Macpherson M, et al. The effects of extended-release stimulant medication on sleep in children with ADHD. J Can Acad Child Adolesc Psychiatry. 2020;29(1):33–43. PubMedPubMedCentral

33.

Poirier A, Corkum P. Night-to-night variability of sleep in children with ADHD and typically developing controls. J Atten Disord. 2018;22(10):942–6. https://doi.org/10.1177/1087054715575065. CrossRefPubMed

34.

Chaput J-P. Sleep patterns, diet quality and energy balance. Physiol Behav. 2013. https://doi.org/10.1016/j.physbeh.2013.09.006. CrossRefPubMed

Titel: Effects of stimulant treatment on sleep in attention deficit hyperactivity disorder (ADHD)
verfasst von: Miriam Sanabra
Tary Gómez-Hinojosa
Carlota Alcover
Oscar Sans
Jose A. Alda
Publikationsdatum: 01.01.2021
Verlag: Springer Japan
Erschienen in: Sleep and Biological Rhythms / Ausgabe 1/2021
Print ISSN: 1446-9235
Elektronische ISSN: 1479-8425
DOI: https://doi.org/10.1007/s41105-020-00289-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

The relationship between sleep quality and breakfast, mid-morning snack, and dinner and physical activity habits among adolescents: a cross-sectional study in Yazd, Iran

Relationship between inflammatory biomarkers and sleep-disordered breathing in patients with heart failure

Snoring and obstructive sleep apnoea as risk factors in SARS-Cov-2: can nasal CPAP during sleep reduce pneumonia risk?

Associated factors of habitual midday napping among Chinese adolescents

Floppy eyelids: sleeping patterns of spouses as indicators of laterality

Might CPAP prevent exacerbation in patients with COVID-19 with or without obstructive sleep apnea?